☆ 4.3 Article

A case of moyamoya disease symptomatized early after nivolumab initiation - Possible association between immune checkpoint inhibitors and moyamoya disease

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Get Full Text
Add to Collection

Journal

CLINICAL NEUROLOGY AND NEUROSURGERY
Volume 200, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.clineuro.2020.106355

Keywords

Moyamoya disease; Nivolmab; Melanoma; Case report; Autoimmunity

Categories

Clinical Neurology Surgery

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.